Clinical Trials Browser

Phase 2 × Withdrawn × FOLFOXIRI protocol × Clear all

NCT03161574 2019-08-08

FOLFOXIRI Chemotherapy Alone as Neoadjuvant Treatment for Circumferential Radial Margin (CRM) Positive Rectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Rectal Neoplasms